Blood Cancer United Rings the Closing Bell at Nasdaq to Celebrate Advancements for Patients

Blood Cancer United Rings Nasdaq Closing Bell to Honor Patients

On September 30, 2026, Blood Cancer United®, previously known as The Leukemia & Lymphoma Society, commemorated the end of Blood Cancer Awareness Month by ringing the Closing Bell at the Nasdaq Stock Market in Times Square, New York City. This event marked not only a celebration of the organization's history since its founding in 1949 but also a tribute to the incredible strides made in the treatment of blood cancers over the past few decades.

The ceremony highlighted a pivotal analysis conducted by Blood Cancer United, revealing that advancements in blood cancer treatments have collectively saved nearly 26 million years of life. This remarkable figure underscores the organization’s commitment to translating decades of scientific research into actionable, life-saving results for patients and their families.

Dr. E. Anders Kolb, the president and CEO of Blood Cancer United, who also authored the analysis, emphasized the significance of this achievement. He stated, "Many blood cancers are not curable, but they are increasingly treatable, allowing people to live longer, often relatively normal lives. For that reason, time is such a meaningful measure of progress. Nearly 26 million life-years represents more birthdays, more graduations, more celebrations and more moments with the people who matter most."

Joining Dr. Kolb at the podium were survivors, volunteers, donors, board members, and staff — all individuals who have contributed to the progress celebrated during this event. Kolb honored their collective efforts, stating, "The progress we celebrate today reflects decades of innovation, advocacy, and partnership. While there is still more work to do, this milestone shows what is possible when we invest in research, expand access to treatment, and remain focused on helping patients live longer and better lives."

Since its inception, Blood Cancer United has focused on supporting individuals affected by various blood cancers through research funding, accessible healthcare advocacy, and personalized support services. The organization has evolved its efforts to adapt to the changing landscape of healthcare and continues to champion the needs of patients facing blood cancer.

In alignment with their mission to further enhance awareness and support, Blood Cancer United has also announced initiatives such as athletic fundraising programs, which actively engage communities in supporting cancer research and treatment.

As Blood Cancer Awareness Month draws to a close, the ringing of the Nasdaq Closing Bell is not only a celebration of past achievements but also a call to action for a future where more lives can be saved through continued research and awareness efforts. Blood Cancer United’s work exemplifies substantial progress in the realm of cancer care, and their commitment to patients is a beacon of hope. For those who wish to learn more about their initiatives or donate to support ongoing research and patient care, further information can be found at Blood Cancer United's website.